✨
AI Summary
- Discussed cell and gene therapy manufacturing challenges with Tatyana Matveeva, Ph.D.
- Emphasized the critical need for quality unit independence in biopharma.
- Highlighted recent compliance violations and the importance of quality-by-design.
Guests on This Episode
More from Life Science Connect
